NL-OMON37880
Completed
Not Applicable
Endovascular renal sympathetic denervation versus spironolactone for treatment-resistant hypertension: a randomized, multicentric study - RRSS study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- hypertensie
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 130
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 and 75 yrs
- •Treatment\-reistant hypertension
- •Willingness to give written informed consent
Exclusion Criteria
- •Secondary forms of hypertension
- •Renal arteries not accessible to intervention
- •Suboptimal dosing of anthypertensive medication
- •White coat hypertension
- •Renal insufficiency (GFR \< 45 ml/min
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Denervation of the nerves to the kidney versus medical treatment in patients with refractory hypertensioEUCTR2011-004995-13-NLErasmus MC
Recruiting
Not Applicable
Renal denervation to improve heart failureSystolic heart failureNL-OMON25325Erasmus Medical CenterRotterdam, the Netherlands70
Recruiting
Not Applicable
Endovascular Renal Sympathetic Denervation using the Boston Scientific Vessix V2 renal denervation system to Improve Heart FailureHeart failure10019280NL-OMON40689Erasmus MC, Universitair Medisch Centrum Rotterdam70
Recruiting
Not Applicable
Comparison of renal sympathetic denervation with spironolactone in patients with still a high blood pressure despite the use of 3 different antihypertensive agents.Hypertension, Renal sympathetic denervation, Sprionolactone. Hypertensie, Renale sympathische denervatie, spironolactonNL-OMON26106Erasmus MC: Department of Radiology120
Active, not recruiting
Not Applicable
/AEUCTR2012-001066-14-ESConsorci Mar Parc de salut de Barcelona ( Parc de Salut Mar)